高原性心脏病合并心房颤动的诊治进展  

Progress in diagnosis and treatment of high altitude heart disease complicated with atrial fibrillation

作　　者：何媛(综述) 杨文慧 郭涛 郭秋哲(审校) HE Yuan;YANG Wenhui;GUO Tao;GUO Qiuzhe(Ultrasonic Department,Fuwai Yunnan Cardiovascular Hospital/Affiliated Cardiovascular Hospital of Kunming Medical University,Kunming Yunnan 650102,China)

机构地区：[1]云南省阜外心血管病医院/昆明医科大学附属心血管病医院超声科,云南昆明650102

出　　处：《云南医药》2024年第2期66-69,共4页Medicine and Pharmacy of Yunnan

摘　　要：中国是全球高原最多的大国,超50%国土的海拔>1500m,高原居民多达8000万。高原心脏病的特殊性导致高原性心脏病和心房颤动常见多发,二者的病诱因和患病率显著多于非高原人群,引发心功能衰竭和缺血性卒中,严重威胁患者生命。充分利用高原习服-适应研究的宝贵资源,探索高原性心脏病合并房颤的流行特征、病因诱因、发病机制、临床表现和防治方法,对开发西部和振兴乡村意义重大。China is the world s largest plateau country,with more than 50%of the land at an altitude of>1500m and 80 million plateau residents.The particularity of high altitude heart disease leads to the frequent occurrence of high altitude heart disease and atrial fibrillation.The causes and prevalence of the two diseases are significantly more than of non-plateau population,causing heart failure and ischemic stroke,which seriously threaten the lives of patients.It is of great significance for the development of the western region and the revitalization of the countryside to make full use of the valuable resources of high altitude acclimatization-adaptation research to explore the epidemiological characteristics,etiology,pathogenesis,clinical manifestations and prevention methods of high altitude heart disease complicated with atrial fibrillation.

关 键 词：高原性心脏病 心房颤动 肺动脉高压 

分 类 号：R541.9[医药卫生—心血管疾病] R541.75[医药卫生—内科学]